TrialClinical rehabilitation2023

Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial.

Cameron Lindsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.